ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment regimens; ORIC-944, an allosteric inhibitor of the polycomb repressive complex 2 for prostate cancer; and ORIC-114, a brain penetrant orally bioavailable irreversible inhibitor designed to selectively target epidermal growth factor receptor and human epidermal growth factor receptor 2 with high potency towards exon 20 insertion mutations. The company is also developing multiple discovery stage precision medicines targeting other cancer resistance mechanisms. It has a license and collaboration agreement with Voronoi Inc.; and a license agreement with Mirati Therapeutics, Inc. The company was incorporated in 2014 and is headquartered in South San Francisco, California. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of Oric Pharmaceuticals Inc..
Oric Pharmaceuticals Inc. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of Oric Pharmaceuticals Inc. are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of Oric Pharmaceuticals Inc. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of Oric Pharmaceuticals Inc. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of Oric Pharmaceuticals Inc. and all latest updates of the company are provided.
The 2025 version of Oric Pharmaceuticals Inc. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 Oric Pharmaceuticals Inc.- Key Facts
2.2 Oric Pharmaceuticals Inc.- Geographic Locations
2.3 Oric Pharmaceuticals Inc.- Subsidiaries and Affiliates
2.4 Oric Pharmaceuticals Inc.- Business Divisions
2.5 Oric Pharmaceuticals Inc.- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. Oric Pharmaceuticals Inc. Strategic Analysis Review
3.1 Oric Pharmaceuticals Inc.- Key Strategies
3.2 Oric Pharmaceuticals Inc.- Company Outlook Statement
3.3 Oric Pharmaceuticals Inc.- SWOT Analysis
3.3.1 Oric Pharmaceuticals Inc.- Key Strengths
3.3.2 Oric Pharmaceuticals Inc.- Key Weaknesses
3.3.3 Oric Pharmaceuticals Inc.- Potential Opportunities
3.3.4 Oric Pharmaceuticals Inc.- Potential Threats
3.4 Oric Pharmaceuticals Inc.- Key Competitors
4. Business Description of the Company
4.1 Oric Pharmaceuticals Inc.- Business Overview
4.2 Oric Pharmaceuticals Inc.- Operations by Segment
5 Products and Services Details
5.1 Oric Pharmaceuticals Inc.- Key Products
5.2 Oric Pharmaceuticals Inc.- Key Service Areas
5.3 Oric Pharmaceuticals Inc.- Key Brands
6 Company Developments
6.1 Oric Pharmaceuticals Inc.- Company History
6.2 Oric Pharmaceuticals Inc.- Latest Developments
7 Financial Analysis
7.1 Oric Pharmaceuticals Inc.- Income Statements
7.2 Oric Pharmaceuticals Inc.- Balance Sheet
7.3 Oric Pharmaceuticals Inc.- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 Oric Pharmaceuticals Inc.- Direct Competitors
8.2 Oric Pharmaceuticals Inc.- Competitor Financial Ratios comparison
8.3 Oric Pharmaceuticals Inc.- Competitor Stock Charts Comparison
8.4 Oric Pharmaceuticals Inc.- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
Get Free Sample
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Why Request a Free Sample?
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
FAQ's
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!
Reach Out to Us
Industries
Resources
Company
Sign up for Offers & Promotions
- Connect with us
- +91 630 95 25755
- sales@swotreports.com
-
Chat on WhatsApp
